National HealthCare Corporation (NHC)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at National HealthCare Corporation.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 9 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 226.00 $ — 96% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
7 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 12.0% failed
- More than 10% revenue growth is expected for the coming year no data
- Share count grows by less than 3% a year 0.4% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 26.2% failed
- Gross margin at 40% or higher and without meaningful erosion 67.8% passed
- Goodwill from acquisitions does not grow faster than revenue 11.2% passed
- Net debt below twice EBITDA 222 m net cash passed
- Operating cash flow covers the profits of the last three years 115 m passed
- Return on capital at 15% or higher, or up versus two years ago 11.3% passed
- Insiders hold at least 10% or are net buyers 18.9% passed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 97.3% below the current price.
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Next Reporting Date
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.39 | -78.80 | 369 | 22.70 | 1.60 | 13 | 5 |
| 2025: Q1 | 2.07 | 22.30 | 374 | 25.70 | 8.60 | 39 | 33 |
| 2025: Q2 | 1.52 | -11.90 | 375 | 28.70 | 6.30 | 63 | 53 |
| 2025: Q3 | 2.50 | -8.30 | 383 | 12.50 | 10.30 | 66 | 57 |
| 2025: Q4 | 1.59 | 309.10 | 387 | 4.60 | 6.40 | 17 | 6 |
| 2026: Q1 | 2.27 | 10.00 | 380 | 1.70 | 9.40 | 63 | 53 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 924 | 61 | 51 | 3.32 | 91 | 670 | 1,087 |
| 2017 | 964 | 54 | 56 | 3.69 | 94 | 703 | 1,097 |
| 2018 | 980 | 56 | 59 | 3.87 | 98 | 733 | 1,081 |
| 2019 | 996 | 49 | 68 | 4.44 | 100 | 779 | 1,287 |
| 2020 | 981 | 48 | 42 | 2.72 | 203 | 795 | 1,362 |
| 2021 | 1,011 | 51 | 139 | 8.99 | 62 | 903 | 1,403 |
| 2022 | 1,074 | 32 | 22 | 1.45 | 9 | 874 | 1,275 |
| 2023 | 1,142 | 57 | 67 | 4.34 | 111 | 909 | 1,311 |
| 2024 | 1,298 | 86 | 102 | 6.53 | 107 | 980 | 1,524 |
| 2025 | 1,511 | 143 | 120 | 7.67 | 185 | 1,069 | 1,526 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
National HealthCare Corporation befasst sich mit dem Betrieb von Dienstleistungen für Pflegeeinrichtungen, betreute und unabhängige Wohneinrichtungen, häusliche Pflege- und Hospizdienste sowie Gesundheitskrankenhäuser. Sie ist in zwei Segmenten tätig: Inpatient und Homecare and Hospice Services.
| Employees | 15,278 |
|---|---|
| Headquarters | Murfreesboro, TN |
| Address | 100 East Vine Street, 37130 Murfreesboro, United States |
| Phone | 615 890 2020 |
| Website | nhccare.com |
| IPO Date | 20. Jan 1987 |
| ISIN | US6359061008 |
| Stock Split | 2:1 on 06/24/1985 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Stephen Fowler Flatt | CEO, President & Director | 1956 |
| Brian Frederick Kidd CPA | Senior VP & CFO | 1975 |
| B. Anderson Flatt Sr. | Senior VP & Chief Information Officer | 1962 |
| Josh A. McCreary | Senior VP, General Counsel & Secretary | 1973 |
| Carl E. Adams | Founder | – |
| Vicki L. Dodson | Senior VP of Patient Services & Chief Nursing Officer | 1962 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.